Citigroup’s Allogene Therapeutics ALLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$862K Sell
353,335
-238,617
-40% -$478K ﹤0.01% 3218
2025
Q4
$811K Sell
591,952
-2,147
-0.4% -$2.83K ﹤0.01% 3272
2025
Q3
$737K Sell
594,099
-48,443
-8% -$57.8K ﹤0.01% 3364
2025
Q2
$726K Sell
642,542
-45,982
-7% -$61.1K ﹤0.01% 3387
2025
Q1
$1.01M Sell
688,524
-27,712
-4% -$52.2K ﹤0.01% 3260
2024
Q4
$1.53M Buy
716,236
+246,926
+53% +$609K ﹤0.01% 3022
2024
Q3
$1.31M Buy
469,310
+394,138
+524% +$1.05M ﹤0.01% 3034
2024
Q2
$175K Sell
75,172
-603,057
-89% -$1.78M ﹤0.01% 3957
2024
Q1
$3.03M Buy
678,229
+643,905
+1,876% +$2.69M ﹤0.01% 2081
2023
Q4
$110K Sell
34,324
-304,432
-90% -$863K ﹤0.01% 4165
2023
Q3
$1.07M Buy
338,756
+57,392
+20% +$252K ﹤0.01% 2445
2023
Q2
$1.4M Sell
281,364
-273,979
-49% -$1.48M ﹤0.01% 2548
2023
Q1
$2.74M Buy
555,343
+210,972
+61% +$1.35M ﹤0.01% 1812
2022
Q4
$2.17M Sell
344,371
-113,418
-25% -$1.05M ﹤0.01% 1975
2022
Q3
$4.94M Buy
457,789
+216,824
+90% +$2.95M ﹤0.01% 1573
2022
Q2
$2.75M Buy
240,965
+121,800
+102% +$1.08M ﹤0.01% 1889
2022
Q1
$1.09M Sell
119,165
-146,219
-55% -$1.52M ﹤0.01% 2886
2021
Q4
$3.96M Buy
265,384
+138,729
+110% +$2.45M ﹤0.01% 2015
2021
Q3
$3.25M Sell
126,655
-71,633
-36% -$1.7M ﹤0.01% 2111
2021
Q2
$5.17M Buy
198,288
+74,327
+60% +$2.12M ﹤0.01% 1861
2021
Q1
$4.38M Buy
123,961
+101,390
+449% +$3.42M ﹤0.01% 1878
2020
Q4
$570K Buy
22,571
+11,806
+110% +$385K ﹤0.01% 4083
2020
Q3
$406K Sell
10,765
-39,105
-78% -$1.47M ﹤0.01% 4034
2020
Q2
$2.14M Buy
49,870
+4,254
+9% +$154K ﹤0.01% 2739
2020
Q1
$887K Buy
45,616
+504
+1% +$12K ﹤0.01% 3304
2019
Q4
$1.17M Buy
45,112
+2,733
+6% +$75.3K ﹤0.01% 3601
2019
Q3
$1.16M Sell
42,379
-50,790
-55% -$1.45M ﹤0.01% 3484
2019
Q2
$2.5M Buy
93,169
+89,284
+2,298% +$2.49M ﹤0.01% 2603
2019
Q1
$112K Sell
3,885
-1,747
-31% -$50.7K ﹤0.01% 5628
2018
Q4
$152K Buy
+5,632
New +$150K ﹤0.01% 5280

Other funds holding ALLO